Skip to main content
Erschienen in:

13.07.2023 | Augenheilkunde | DFP-Fortbildung Zur Zeit gratis

Antikoagulation und Thrombozytenfunktionshemmung

Was in der augenärztlichen Praxis zu beachten ist

verfasst von: Prof. Dr. med. Oliver Zeitz, Laura Wernecke, Nicolas Feltgen, Christoph Sucker, Jürgen Koscielny, Thomas Dörner

Erschienen in: Spektrum der Augenheilkunde | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Zusammenfassung

Viele Augenerkrankungen, die eine operative Intervention erfordern, sind Erkrankungen des älteren Menschen. Daher bestehen häufig internistische Komorbiditäten. In deren Behandlung spielt in vielen Fällen die medikamentöse Hemmung der Blutgerinnung eine wichtige Rolle. Es gibt verschiedene Möglichkeiten, die Blutgerinnung pharmakologisch zu beeinflussen, wobei die Zahl der Optionen in den letzten Jahren durch die Einführung neuer Medikamente zugenommen hat. Der Beitrag bietet einen Überblick darüber, welche Möglichkeiten es heute gibt, die Blutgerinnung therapeutisch zu hemmen, und warum dies aus internistischer Sicht wichtig ist. Daneben werden die Grundzüge der Therapiesteuerung dargestellt. Des Weiteren wird die pharmakologische Hemmung der Blutgerinnung im Kontext mit Augenoperationen erörtert. Insbesondere wird die verfügbare Literatur im Hinblick auf die Notwendigkeit, die Therapie mit Gerinnungshemmern für Augenoperationen zu unterbrechen oder umzustellen, analysiert.
Literatur
1.
Zurück zum Zitat Cohen AT, Spiro TE, Buller HR et al (2013) Rivaroxaban for thromboprophylaxis in acutely ill medical patients. N Engl J Med 368:513–523PubMedCrossRef Cohen AT, Spiro TE, Buller HR et al (2013) Rivaroxaban for thromboprophylaxis in acutely ill medical patients. N Engl J Med 368:513–523PubMedCrossRef
2.
Zurück zum Zitat Goldhaber SZ, Leizorovicz A, Kakkar AK et al (2011) Apixaban versus enoxaparin for thromboprophylaxis in medically ill patients. N Engl J Med 365:2167–2177PubMedCrossRef Goldhaber SZ, Leizorovicz A, Kakkar AK et al (2011) Apixaban versus enoxaparin for thromboprophylaxis in medically ill patients. N Engl J Med 365:2167–2177PubMedCrossRef
3.
Zurück zum Zitat Alexander JH, Lopes RD, James S et al (2011) Apixaban with antiplatelet therapy after acute coronary syndrome. N Engl J Med 365:699–708PubMedCrossRef Alexander JH, Lopes RD, James S et al (2011) Apixaban with antiplatelet therapy after acute coronary syndrome. N Engl J Med 365:699–708PubMedCrossRef
4.
Zurück zum Zitat Lum DJ, Ross PA, Bishop MA et al (2017) Evaluation of a standardized perioperative management protocol in the adult hematology anticoagulation management service. Ann Pharmacother 51:1077–1083PubMedCrossRef Lum DJ, Ross PA, Bishop MA et al (2017) Evaluation of a standardized perioperative management protocol in the adult hematology anticoagulation management service. Ann Pharmacother 51:1077–1083PubMedCrossRef
6.
Zurück zum Zitat Gurbel PA, Tantry US (2014) Antiplatelet and anticoagulant agents in heart failure: current status and future perspectives. JACC Heart Fail 2:1–14PubMedCrossRef Gurbel PA, Tantry US (2014) Antiplatelet and anticoagulant agents in heart failure: current status and future perspectives. JACC Heart Fail 2:1–14PubMedCrossRef
8.
Zurück zum Zitat Lettau M, Schrezenmeier EV, Specker C et al (2020) Lupus and thrombophilia : antiphospholipid syndrome. Z Rheumatol 79:332–341PubMedCrossRef Lettau M, Schrezenmeier EV, Specker C et al (2020) Lupus and thrombophilia : antiphospholipid syndrome. Z Rheumatol 79:332–341PubMedCrossRef
9.
Zurück zum Zitat Tektonidou MG, Andreoli L, Limper M et al (2019) EULAR recommendations for the management of antiphospholipid syndrome in adults. Ann Rheum Dis 78:1296–1304PubMedCrossRef Tektonidou MG, Andreoli L, Limper M et al (2019) EULAR recommendations for the management of antiphospholipid syndrome in adults. Ann Rheum Dis 78:1296–1304PubMedCrossRef
10.
Zurück zum Zitat Werth S, Breslin T, Niainle F et al (2015) Bleeding risk, management and outcome in patients receiving non-VKA oral anticoagulants (NOAcs). Am J Cardiovasc Drugs 15:235–242PubMedCrossRef Werth S, Breslin T, Niainle F et al (2015) Bleeding risk, management and outcome in patients receiving non-VKA oral anticoagulants (NOAcs). Am J Cardiovasc Drugs 15:235–242PubMedCrossRef
11.
Zurück zum Zitat Roffi M, Patrono C, Collet JP et al (2016) 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). G Ital Cardiol 17:831–872 Roffi M, Patrono C, Collet JP et al (2016) 2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC). G Ital Cardiol 17:831–872
12.
Zurück zum Zitat Steg PG, James SK, Atar D et al (2012) ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 33:2569–2619PubMedCrossRef Steg PG, James SK, Atar D et al (2012) ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation. Eur Heart J 33:2569–2619PubMedCrossRef
13.
Zurück zum Zitat Anonymous (Stand 1018) Fachinformation Brilique® 90 mg/60 mg. Anonymous (Stand 1018) Fachinformation Brilique® 90 mg/60 mg.
14.
Zurück zum Zitat Anonymous (Stand 2019) Fachinformation Efient®. Anonymous (Stand 2019) Fachinformation Efient®.
15.
Zurück zum Zitat Anonymous (Stand 2018) Fachinformation Plavix®. Anonymous (Stand 2018) Fachinformation Plavix®.
17.
Zurück zum Zitat Korte W, Cattaneo M, Chassot PG et al (2011) Peri-operative management of antiplatelet therapy in patients with coronary artery disease: joint position paper by members of the working group on Perioperative Haemostasis of the Society on Thrombosis and Haemostasis Research (GTH), the working group on Perioperative Coagulation of the Austrian Society for Anesthesiology, Resuscitation and Intensive Care (ÖGARI) and the Working Group Thrombosis of the European Society for Cardiology (ESC). Thromb Haemost 105:743–749PubMedCrossRef Korte W, Cattaneo M, Chassot PG et al (2011) Peri-operative management of antiplatelet therapy in patients with coronary artery disease: joint position paper by members of the working group on Perioperative Haemostasis of the Society on Thrombosis and Haemostasis Research (GTH), the working group on Perioperative Coagulation of the Austrian Society for Anesthesiology, Resuscitation and Intensive Care (ÖGARI) and the Working Group Thrombosis of the European Society for Cardiology (ESC). Thromb Haemost 105:743–749PubMedCrossRef
18.
Zurück zum Zitat Zeymer U, Koscielny J, Von Heymann C et al (2016) Bleeding in patients receiving dual antiplatelet therapy after acute coronary syndrome—significance, prevention and interdisciplinary management. Dtsch Med Wochenschr 141:1107–1111PubMed Zeymer U, Koscielny J, Von Heymann C et al (2016) Bleeding in patients receiving dual antiplatelet therapy after acute coronary syndrome—significance, prevention and interdisciplinary management. Dtsch Med Wochenschr 141:1107–1111PubMed
19.
Zurück zum Zitat Gurbel PA, Bliden KP, Butler K et al (2009) Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the ONSET/OFFSET study. Circulation 120:2577–2585PubMedCrossRef Gurbel PA, Bliden KP, Butler K et al (2009) Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the ONSET/OFFSET study. Circulation 120:2577–2585PubMedCrossRef
20.
Zurück zum Zitat Oprea AD, Popescu WM (2013) Perioperative management of antiplatelet therapy. Br J Anaesth 111(Suppl 1):i3–i17PubMedCrossRef Oprea AD, Popescu WM (2013) Perioperative management of antiplatelet therapy. Br J Anaesth 111(Suppl 1):i3–i17PubMedCrossRef
21.
Zurück zum Zitat Fleisher LA, Fleischmann KE, Auerbach AD et al (2014) 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol 64:e77–e137PubMedCrossRef Fleisher LA, Fleischmann KE, Auerbach AD et al (2014) 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines. J Am Coll Cardiol 64:e77–e137PubMedCrossRef
22.
Zurück zum Zitat Koscielny J, Von Heymann C, Zeymer U et al (2017) Dual antiplatelet therapy in the perioperative period—to continue or discontinue treatment? Dtsch Med Wochenschr 142:1223–1230PubMed Koscielny J, Von Heymann C, Zeymer U et al (2017) Dual antiplatelet therapy in the perioperative period—to continue or discontinue treatment? Dtsch Med Wochenschr 142:1223–1230PubMed
23.
Zurück zum Zitat Frontera JA, Lewin JJ, Rabinstein AA et al (2016) Guideline for reversal of antithrombotics in Intracranial hemorrhage: a statement for healthcare professionals from the neurocritical care society and society of critical care medicine. Neurocrit Care 24:6–46PubMedCrossRef Frontera JA, Lewin JJ, Rabinstein AA et al (2016) Guideline for reversal of antithrombotics in Intracranial hemorrhage: a statement for healthcare professionals from the neurocritical care society and society of critical care medicine. Neurocrit Care 24:6–46PubMedCrossRef
24.
Zurück zum Zitat Hindricks G, Potpara T, Dagres N et al (2021) 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 42:373–498PubMedCrossRef Hindricks G, Potpara T, Dagres N et al (2021) 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J 42:373–498PubMedCrossRef
25.
Zurück zum Zitat Calenda E, Cardon-Guiton A, Genevois O et al (2011) Peribulbar block in 500 patients scheduled for eye procedures and treated with acetyl salicylic acid. Acta Anaesthesiol Taiwan 49:141–143PubMedCrossRef Calenda E, Cardon-Guiton A, Genevois O et al (2011) Peribulbar block in 500 patients scheduled for eye procedures and treated with acetyl salicylic acid. Acta Anaesthesiol Taiwan 49:141–143PubMedCrossRef
26.
Zurück zum Zitat Calenda E, Genevois O, Cardon A et al (2014) Peribulbar anesthesia in 750 patients treated with oral anticoagulants. Int J Ophthalmol 7:110–113PubMedPubMedCentral Calenda E, Genevois O, Cardon A et al (2014) Peribulbar anesthesia in 750 patients treated with oral anticoagulants. Int J Ophthalmol 7:110–113PubMedPubMedCentral
27.
Zurück zum Zitat Calenda E, Lamothe L, Genevois O et al (2012) Peribulbar block in patients scheduled for eye procedures and treated with clopidogrel. J Anesth 26:779–782PubMedCrossRef Calenda E, Lamothe L, Genevois O et al (2012) Peribulbar block in patients scheduled for eye procedures and treated with clopidogrel. J Anesth 26:779–782PubMedCrossRef
28.
Zurück zum Zitat Huebert I, Heinicke N, Kook D et al (2015) Dual platelet inhibition in cases of severe retrobulbar hemorrhage following retrobulbar and peribulbar anesthesia. J Cataract Refract Surg 41:2092–2101PubMedCrossRef Huebert I, Heinicke N, Kook D et al (2015) Dual platelet inhibition in cases of severe retrobulbar hemorrhage following retrobulbar and peribulbar anesthesia. J Cataract Refract Surg 41:2092–2101PubMedCrossRef
29.
Zurück zum Zitat Shin YI, Sung JY, Sagong M et al (2018) Risk factors for breakthrough vitreous hemorrhage after intravitreal anti-VEGF injection in age-related macular degeneration with submacular hemorrhage. Sci Rep 8:10560PubMedPubMedCentralCrossRefADS Shin YI, Sung JY, Sagong M et al (2018) Risk factors for breakthrough vitreous hemorrhage after intravitreal anti-VEGF injection in age-related macular degeneration with submacular hemorrhage. Sci Rep 8:10560PubMedPubMedCentralCrossRefADS
30.
Zurück zum Zitat Feltgen N, Mele B, Dietlein T et al (2018) Management of anticoagulants in ophthalmic surgery—a survey among ophthalmic surgeons in Germany. Ophthalmologe 115:585–591PubMedCrossRef Feltgen N, Mele B, Dietlein T et al (2018) Management of anticoagulants in ophthalmic surgery—a survey among ophthalmic surgeons in Germany. Ophthalmologe 115:585–591PubMedCrossRef
31.
Zurück zum Zitat Cheung JJC, Liu S, Li KKW (2019) Phacoemulsification cataract surgery in patients receiving novel oral anticoagulant medications. Int Ophthalmol 39:623–630PubMedCrossRef Cheung JJC, Liu S, Li KKW (2019) Phacoemulsification cataract surgery in patients receiving novel oral anticoagulant medications. Int Ophthalmol 39:623–630PubMedCrossRef
32.
Zurück zum Zitat Grzybowski A, Ascaso FJ, Kupidura-Majewski K et al (2015) Continuation of anticoagulant and antiplatelet therapy during phacoemulsification cataract surgery. Curr Opin Ophthalmol 26:28–33PubMedCrossRef Grzybowski A, Ascaso FJ, Kupidura-Majewski K et al (2015) Continuation of anticoagulant and antiplatelet therapy during phacoemulsification cataract surgery. Curr Opin Ophthalmol 26:28–33PubMedCrossRef
33.
Zurück zum Zitat Katz J, Feldman MA, Bass EB et al (2003) Risks and benefits of anticoagulant and antiplatelet medication use before cataract surgery. Ophthalmology 110:1784–1788PubMedCrossRef Katz J, Feldman MA, Bass EB et al (2003) Risks and benefits of anticoagulant and antiplatelet medication use before cataract surgery. Ophthalmology 110:1784–1788PubMedCrossRef
34.
Zurück zum Zitat Kiire CA, Mukherjee R, Ruparelia N et al (2014) Managing antiplatelet and anticoagulant drugs in patients undergoing elective ophthalmic surgery. Br J Ophthalmol 98:1320–1324PubMedCrossRef Kiire CA, Mukherjee R, Ruparelia N et al (2014) Managing antiplatelet and anticoagulant drugs in patients undergoing elective ophthalmic surgery. Br J Ophthalmol 98:1320–1324PubMedCrossRef
35.
Zurück zum Zitat Douketis JD, Spyropoulos AC, Spencer FA et al (2012) Perioperative management of antithrombotic therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines. Chest 141:e326S–e350SPubMedPubMedCentralCrossRef Douketis JD, Spyropoulos AC, Spencer FA et al (2012) Perioperative management of antithrombotic therapy: antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines. Chest 141:e326S–e350SPubMedPubMedCentralCrossRef
36.
Zurück zum Zitat Kristensen SD, Knuuti J, Saraste A et al (2014) 2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). Eur J Anaesthesiol 31:517–573PubMedCrossRef Kristensen SD, Knuuti J, Saraste A et al (2014) 2014 ESC/ESA Guidelines on non-cardiac surgery: cardiovascular assessment and management: The Joint Task Force on non-cardiac surgery: cardiovascular assessment and management of the European Society of Cardiology (ESC) and the European Society of Anaesthesiology (ESA). Eur J Anaesthesiol 31:517–573PubMedCrossRef
37.
Zurück zum Zitat Jeganathan VS, Ghosh S, Ruddle JB et al (2008) Risk factors for delayed suprachoroidal haemorrhage following glaucoma surgery. Br J Ophthalmol 92:1393–1396PubMedCrossRef Jeganathan VS, Ghosh S, Ruddle JB et al (2008) Risk factors for delayed suprachoroidal haemorrhage following glaucoma surgery. Br J Ophthalmol 92:1393–1396PubMedCrossRef
38.
Zurück zum Zitat Sozeri Y, Salim S (2018) Anticlotting agents and the surgical management of glaucoma. Curr Opin Ophthalmol 29:185–189PubMedCrossRef Sozeri Y, Salim S (2018) Anticlotting agents and the surgical management of glaucoma. Curr Opin Ophthalmol 29:185–189PubMedCrossRef
39.
Zurück zum Zitat Cobb CJ, Chakrabarti S, Chadha V et al (2007) The effect of aspirin and warfarin therapy in trabeculectomy. Eye (Lond) 21:598–603PubMedCrossRef Cobb CJ, Chakrabarti S, Chadha V et al (2007) The effect of aspirin and warfarin therapy in trabeculectomy. Eye (Lond) 21:598–603PubMedCrossRef
40.
Zurück zum Zitat Law SK, Song BJ, Yu F et al (2008) Hemorrhagic complications from glaucoma surgery in patients on anticoagulation therapy or antiplatelet therapy. Am J Ophthalmol 145:736–746PubMedCrossRef Law SK, Song BJ, Yu F et al (2008) Hemorrhagic complications from glaucoma surgery in patients on anticoagulation therapy or antiplatelet therapy. Am J Ophthalmol 145:736–746PubMedCrossRef
41.
Zurück zum Zitat Widder RA, Lappas A, Rennings C et al (2020) Influence of oral anticoagulation on success rates and risk of bleeding events after iStent inject implantation combined with phacoemulsification. Graefes Arch Clin Exp Ophthalmol 258:2483–2487 Widder RA, Lappas A, Rennings C et al (2020) Influence of oral anticoagulation on success rates and risk of bleeding events after iStent inject implantation combined with phacoemulsification. Graefes Arch Clin Exp Ophthalmol 258:2483–2487
42.
Zurück zum Zitat Bemme S, Lauermann P, Striebe NA et al (2020) Risk of perioperative bleeding complications in rhegmatogenous retinal detachment surgery: a retrospective single-center study. Graefes Arch Clin Exp Ophthalmol 258:961–969PubMedCrossRef Bemme S, Lauermann P, Striebe NA et al (2020) Risk of perioperative bleeding complications in rhegmatogenous retinal detachment surgery: a retrospective single-center study. Graefes Arch Clin Exp Ophthalmol 258:961–969PubMedCrossRef
45.
Zurück zum Zitat Dayani PN, Grand MG (2006) Maintenance of warfarin anticoagulation for patients undergoing vitreoretinal surgery. Trans Am Ophthalmol Soc 104:149–160PubMedPubMedCentral Dayani PN, Grand MG (2006) Maintenance of warfarin anticoagulation for patients undergoing vitreoretinal surgery. Trans Am Ophthalmol Soc 104:149–160PubMedPubMedCentral
46.
Zurück zum Zitat Meillon C, Gabrielle PH, Bron AM et al (2019) Antiplatelet and anticoagulant agents in vitreoretinal surgery: a prospective multicenter study involving 804 patients. Graefes Arch Clin Exp Ophthalmol 257:427PubMedCrossRef Meillon C, Gabrielle PH, Bron AM et al (2019) Antiplatelet and anticoagulant agents in vitreoretinal surgery: a prospective multicenter study involving 804 patients. Graefes Arch Clin Exp Ophthalmol 257:427PubMedCrossRef
47.
Zurück zum Zitat Oh J, Smiddy WE, Kim SS (2011) Antiplatelet and anticoagulation therapy in vitreoretinal surgery. Am J Ophthalmol 151:934–939.e3PubMedCrossRef Oh J, Smiddy WE, Kim SS (2011) Antiplatelet and anticoagulation therapy in vitreoretinal surgery. Am J Ophthalmol 151:934–939.e3PubMedCrossRef
48.
Zurück zum Zitat Fabinyi DC, O’neill EC, Connell PP et al (2011) Vitreous cavity haemorrhage post-vitrectomy for diabetic eye disease: the effect of perioperative anticoagulation and antiplatelet agents. Clin Experiment Ophthalmol 39:878–884PubMedCrossRef Fabinyi DC, O’neill EC, Connell PP et al (2011) Vitreous cavity haemorrhage post-vitrectomy for diabetic eye disease: the effect of perioperative anticoagulation and antiplatelet agents. Clin Experiment Ophthalmol 39:878–884PubMedCrossRef
49.
Zurück zum Zitat Brown JS, Mahmoud TH (2011) Anticoagulation and clinically significant postoperative vitreous hemorrhage in diabetic vitrectomy. Retina 31:1983–1987PubMedCrossRef Brown JS, Mahmoud TH (2011) Anticoagulation and clinically significant postoperative vitreous hemorrhage in diabetic vitrectomy. Retina 31:1983–1987PubMedCrossRef
50.
Zurück zum Zitat Patel R, Charles S, Jalil A (2017) Antiplatelets and anticoagulants in vitreoretinal surgery, with a special emphasis on novel anticoagulants: a national survey and review. Graefes Arch Clin Exp Ophthalmol 255:1275–1285PubMedCrossRef Patel R, Charles S, Jalil A (2017) Antiplatelets and anticoagulants in vitreoretinal surgery, with a special emphasis on novel anticoagulants: a national survey and review. Graefes Arch Clin Exp Ophthalmol 255:1275–1285PubMedCrossRef
51.
Zurück zum Zitat Hass AN, Penne RB, Stefanyszyn MA et al (2004) Incidence of postblepharoplasty orbital hemorrhage and associated visual loss. Ophthalmic Plast Reconstr Surg 20:426–432PubMedCrossRef Hass AN, Penne RB, Stefanyszyn MA et al (2004) Incidence of postblepharoplasty orbital hemorrhage and associated visual loss. Ophthalmic Plast Reconstr Surg 20:426–432PubMedCrossRef
52.
Zurück zum Zitat Mejia JD, Egro FM, Nahai F (2011) Visual loss after blepharoplasty: incidence, management, and preventive measures. Aesthet Surg J 31:21–29PubMedCrossRef Mejia JD, Egro FM, Nahai F (2011) Visual loss after blepharoplasty: incidence, management, and preventive measures. Aesthet Surg J 31:21–29PubMedCrossRef
53.
Zurück zum Zitat Custer PL, Trinkaus KM (2002) Hemorrhagic complications of oculoplastic surgery. Ophthalmic Plast Reconstr Surg 18:409–415PubMedCrossRef Custer PL, Trinkaus KM (2002) Hemorrhagic complications of oculoplastic surgery. Ophthalmic Plast Reconstr Surg 18:409–415PubMedCrossRef
54.
Zurück zum Zitat Esparaz ES, Sobel RK (2015) Perioperative management of anticoagulants and antiplatelet agents in oculoplastic surgery. Curr Opin Ophthalmol 26:422–428PubMedCrossRef Esparaz ES, Sobel RK (2015) Perioperative management of anticoagulants and antiplatelet agents in oculoplastic surgery. Curr Opin Ophthalmol 26:422–428PubMedCrossRef
55.
Zurück zum Zitat Ing E, Douketis J (2014) New oral anticoagulants and oculoplastic surgery. Can J Ophthalmol 49:123–127PubMedCrossRef Ing E, Douketis J (2014) New oral anticoagulants and oculoplastic surgery. Can J Ophthalmol 49:123–127PubMedCrossRef
56.
Zurück zum Zitat Kraft CT, Bellile E, Baker SR et al (2015) Anticoagulant complications in facial plastic and reconstructive surgery. JAMA Facial Plast Surg 17:103–107PubMedCrossRef Kraft CT, Bellile E, Baker SR et al (2015) Anticoagulant complications in facial plastic and reconstructive surgery. JAMA Facial Plast Surg 17:103–107PubMedCrossRef
57.
Zurück zum Zitat Makuloluwa AK, Tiew S, Briggs M (2019) Peri-operative management of ophthalmic patients on anti-thrombotic agents: a literature review. Eye (Lond) 33:1044–1059PubMedCrossRef Makuloluwa AK, Tiew S, Briggs M (2019) Peri-operative management of ophthalmic patients on anti-thrombotic agents: a literature review. Eye (Lond) 33:1044–1059PubMedCrossRef
58.
Zurück zum Zitat Robbins SL, Wang JW, Frazer JR et al (2019) Anticoagulation: a practical guide for strabismus surgeons. J AAPOS 23:193–199PubMedCrossRef Robbins SL, Wang JW, Frazer JR et al (2019) Anticoagulation: a practical guide for strabismus surgeons. J AAPOS 23:193–199PubMedCrossRef
59.
60.
Zurück zum Zitat Arès C, Superstein R (2006) Retrobulbar hemorrhage following strabismus surgery. J AAPOS 10:594–595PubMedCrossRef Arès C, Superstein R (2006) Retrobulbar hemorrhage following strabismus surgery. J AAPOS 10:594–595PubMedCrossRef
61.
Zurück zum Zitat Kemp PS, Larson SA, Drack AV (2014) Strabismus surgery in patients receiving warfarin anticoagulation. J AAPOS 18:84–86PubMedCrossRef Kemp PS, Larson SA, Drack AV (2014) Strabismus surgery in patients receiving warfarin anticoagulation. J AAPOS 18:84–86PubMedCrossRef
62.
Zurück zum Zitat Kuhli-Hattenbach C, Miesbach W, Scharrer I et al (2012) Massive subretinal hemorrhage and anticoagulants. An unfortunate combination? Ophthalmologe 109:665–669PubMedCrossRef Kuhli-Hattenbach C, Miesbach W, Scharrer I et al (2012) Massive subretinal hemorrhage and anticoagulants. An unfortunate combination? Ophthalmologe 109:665–669PubMedCrossRef
63.
Zurück zum Zitat Ying GS, Maguire MG, Daniel E et al (2016) Association between antiplatelet or anticoagulant drugs and retinal or subretinal hemorrhage in the comparison of age-related macular degeneration treatments trials. Ophthalmology 123:352–360PubMedCrossRef Ying GS, Maguire MG, Daniel E et al (2016) Association between antiplatelet or anticoagulant drugs and retinal or subretinal hemorrhage in the comparison of age-related macular degeneration treatments trials. Ophthalmology 123:352–360PubMedCrossRef
64.
Zurück zum Zitat Azar G, Mauget-Faysse M, Nyouma J et al (2015) Occurrence of macular hematoma after ranibizumab treatment for age-related macular degeneration. Eur J Ophthalmol 25:163–167PubMedCrossRef Azar G, Mauget-Faysse M, Nyouma J et al (2015) Occurrence of macular hematoma after ranibizumab treatment for age-related macular degeneration. Eur J Ophthalmol 25:163–167PubMedCrossRef
65.
Zurück zum Zitat Buitendijk GHS, Schauwvlieghe AME, Vingerling JR et al (2018) Antiplatelet and anticoagulant drugs do not affect visual outcome in neovascular age-related macular degeneration in the BRAMD trial. Am J Ophthalmol 187:130–137PubMedCrossRef Buitendijk GHS, Schauwvlieghe AME, Vingerling JR et al (2018) Antiplatelet and anticoagulant drugs do not affect visual outcome in neovascular age-related macular degeneration in the BRAMD trial. Am J Ophthalmol 187:130–137PubMedCrossRef
66.
Zurück zum Zitat El-Sanhouri AA, Foster RE, Petersen MR et al (2011) Retinal tears after posterior vitreous detachment and vitreous hemorrhage in patients on systemic anticoagulants. Eye (Lond) 25:1016–1019PubMedCrossRef El-Sanhouri AA, Foster RE, Petersen MR et al (2011) Retinal tears after posterior vitreous detachment and vitreous hemorrhage in patients on systemic anticoagulants. Eye (Lond) 25:1016–1019PubMedCrossRef
67.
Zurück zum Zitat Jun JH, Hwang JC (2015) Association of rivaroxaban anticoagulation and spontaneous vitreous hemorrhage. JAMA Ophthalmol 133:1184–1186PubMedCrossRef Jun JH, Hwang JC (2015) Association of rivaroxaban anticoagulation and spontaneous vitreous hemorrhage. JAMA Ophthalmol 133:1184–1186PubMedCrossRef
Metadaten
Titel
Antikoagulation und Thrombozytenfunktionshemmung
Was in der augenärztlichen Praxis zu beachten ist
verfasst von
Prof. Dr. med. Oliver Zeitz
Laura Wernecke
Nicolas Feltgen
Christoph Sucker
Jürgen Koscielny
Thomas Dörner
Publikationsdatum
13.07.2023
Verlag
Springer Vienna
Schlagwort
Augenheilkunde
Erschienen in
Spektrum der Augenheilkunde / Ausgabe 1/2024
Print ISSN: 0930-4282
Elektronische ISSN: 1613-7523
DOI
https://doi.org/10.1007/s00717-023-00537-0

Weitere Artikel der Ausgabe 1/2024

Spektrum der Augenheilkunde 1/2024 Zur Ausgabe

14.07.2023 | Sammlung

Das könnte Sie auch interessieren